Amersham Bioprocess 11000846 Page 11
11
Downstream
thirty seven
Program Committee
Dr. Steve Chamow, (Abgenix) Chairman
Dr. Andrew Ramelmeier (Centocor)
Dr. Jörg Thömmes (Biogen Idec)
Dr. Joachim Walter (GE Healthcare)
JJ
JJJoin us at
oin us at
oin us at
oin us at
oin us at
www. gabconferences.com
Hotel Le Méridien, Nice, France
3rd International Symposium on Downstream Processing of
Genetically Engineered Antibodies and Related Molecules
October 35, 2004
For more information visit
Interested in Monoclonal Antibodies?
Don't miss this opportunity to meet leaders
in the field and hear the latest trends
· Harvest methods for high titer/high cell density processes
· Disposable technology for early phase clinical manufacturing
· Opportunities for platform design of GAb processes
· Analytical and characterization issues
· Formulation challenges of high concentration Gabs
· Engineering to optimize GAb molecular properties
· Glycosylation, PEGylation
· Alternative modes of chromatography for capture
· Improved design of affinity ligands
Submit your abstract by June 18th
Meeting
announcement
